```html

Junctional Tachycardia (AV Nodal Re‑entrant Tachycardia)

Overview

Junctional tachycardia – more precisely called **AV nodal re‑entrant tachycardia (AVNRT)** – is one of the most common types of supraventricular tachycardia (SVT). It originates from a re‑entry circuit within or very near the atrioventricular (AV) node, causing the heart to beat rapidly (150‑250 beats per minute) without a normal trigger from the sinus node.

• Who it affects: AVNRT can occur at any age, but peak incidence is in people aged 20‑40 years. Women are about 1.5‑2 times more likely to develop AVNRT than men.
• Prevalence: SVT accounts for roughly 2 % of the general population; AVNRT represents 50‑60 % of all SVT episodes, making it the single most frequent SVT diagnosis (≈1 in 250 adults will experience an AVNRT episode in their lifetime)【1】.
• Nature of the condition: It is usually benign, but the rapid heart rate can cause symptoms, impair quality of life, and rarely lead to serious complications if left untreated.

Symptoms

Symptoms can vary widely and may be mild enough to be missed, or so severe that they prompt an emergency department visit.

Typical manifestations

• Palpitations: A sudden “fluttering,” “racing,” or “pounding” sensation in the chest.
• Rapid heartbeat (tachycardia): Measured rates of 150‑250 bpm on a pulse oximeter or ECG.
• Dizziness or light‑headedness: Due to reduced cardiac output during the fast rhythm.
• Shortness of breath: Especially with exertion or when the episode lasts more than a few minutes.
• Chest discomfort or pressure: Non‑ischemic pain that may mimic angina.
• Fatigue: Frequent episodes can leave patients feeling exhausted.
• Blurred vision or “blackout” feeling: Transient cerebral hypoperfusion.

Atypical or less common symptoms

• Syncope (fainting) – rare, usually when the rate exceeds 200 bpm for a prolonged period.
• Heart palpitations that start abruptly and stop suddenly (often described as “stopping the heart”).
• Feeling of anxiety or panic – can be mistaken for a panic attack.

Causes and Risk Factors

AVNRT is caused by an electrical “short‑circuit” within the AV node. The AV node normally has two pathways:

• Fast pathway: Conducts quickly but has a longer refractory period.
• Slow pathway: Conducts more slowly and recovers faster.

When a premature atrial beat encounters these pathways, it may travel down the slow pathway while the fast pathway is still refractory, then retrograde up the fast pathway, creating a loop that repeats—this is the re‑entry circuit.

Risk factors

• Female gender.
• Age 20‑40 (though it can appear at any age).
• Family history of SVT (genetic predisposition for dual AV nodal pathways).
• Caffeine, nicotine, or other stimulants that increase sinus rate.
• Excessive alcohol intake.
• Electrolyte disturbances (e.g., low potassium, magnesium).
• Underlying heart disease (congenital heart disease, myocarditis) can increase the likelihood of AVNRT co‑existing with other arrhythmias.

Diagnosis

Because the episode can be fleeting, a combination of patient history, bedside testing, and sometimes prolonged monitoring is required.

Initial evaluation

• History & physical exam: Onset, duration, triggers, and symptom pattern.
• Pulse assessment: Regular, rapid pulse (often >150 bpm) with a “narrow” QRS complex on ECG.

Diagnostic tests

• 12‑lead Electrocardiogram (ECG): During an episode, AVNRT shows a regular, narrow‑complex tachycardia without distinct P waves or with “pseudo‑R’” waves in V1. The atrial activity is often hidden within or just after the QRS complex.
• Event recorder or Holter monitor: Continuous recording for 24‑48 hours (Holter) or patient‑activated devices for weeks (event recorder) to capture intermittent episodes.
• Implantable loop recorder: Considered when episodes are very infrequent.
• Electrophysiology (EP) study: Invasive catheter study that maps the heart’s electrical pathways. It confirms the diagnosis and can treat AVNRT in the same session via catheter ablation.
• Blood tests: Rule out metabolic triggers (thyroid function, electrolytes, drug levels).

Treatment Options

Management is individualized based on symptom severity, frequency, and patient preference.

Acute termination (during an episode)

• Vagal maneuvers: The first line – coughing, Valsalva maneuver, cold water face immersion. Success rates 20‑40 %.
• Medications:
  • **Adenosine** (0.5–6 mg rapid IV bolus) – stops the re‑entry circuit within seconds; diagnostic and therapeutic.
  • **Beta‑blockers** (e.g., metoprolol) or **non‑dihydropyridine calcium‑channel blockers** (e.g., verapamil, diltiazem) – can be given IV or orally if vagal maneuvers fail.

Long‑term management

• Medication therapy: For patients who have frequent episodes and are not candidates for ablation.
  • Low‑dose beta‑blockers (metoprolol 25‑100 mg daily).
  • Calcium‑channel blockers (verapamil 120‑240 mg daily).
  • Anti‑arrhythmic drugs such as flecainide or propafenone (reserved for refractory cases).
• Catheter ablation: The definitive treatment. Radiofrequency or cryoablation of the slow pathway eliminates the circuit in >95 % of cases with <1 % serious complication rate【2】. Most patients are discharged the same day or after an overnight observation.
• Lifestyle modifications: Reduce triggers (caffeine, alcohol, nicotine), maintain adequate hydration, and manage stress.

Living with Junctional Tachycardia (AV Nodal Re‑entrant Tachycardia)

Even after successful treatment, thoughtful daily habits help keep episodes at bay and improve overall heart health.

• Keep a symptom diary: Record episode timing, duration, possible triggers, and heart rate. This helps clinicians fine‑tune therapy.
• Monitor heart rate: Use a wearable or manual pulse check when you feel symptoms. Knowing your baseline (usually 60‑80 bpm) makes abnormal spikes easier to spot.
• Stay hydrated: Dehydration can increase sympathetic tone and precipitate tachycardia.
• Limit stimulants: Caffeine >200 mg/day, energy drinks, and nicotine may provoke episodes.
• Regular exercise: Moderate aerobic activity improves autonomic balance. Start slowly and avoid extreme exertion that spikes heart rate >180 bpm.
• Stress management: Techniques such as deep‑breathing, meditation, or yoga can reduce vagal tone fluctuations.
• Medication adherence: Take prescribed drugs exactly as directed; do not stop abruptly without consulting a physician.
• Follow‑up appointments: Annual check‑ups, or sooner after any change in symptoms.

Prevention

While the anatomical substrate (dual AV nodal pathways) cannot be altered, you can lessen the likelihood of triggering an episode.

• Maintain a balanced diet rich in potassium and magnesium (bananas, leafy greens, nuts).
• Avoid excessive caffeine (>2 cups of coffee) and alcohol, especially binge drinking.
• Quit smoking and limit exposure to second‑hand smoke.
• Manage underlying conditions—thyroid disease, sleep apnea, or electrolyte disorders.
• Practice regular sleep hygiene (7‑9 hours/night) to keep autonomic balance stable.
• Stay up‑to‑date on vaccinations (e.g., flu, COVID‑19) to reduce the chance of infection‑related arrhythmias.

Complications

If left untreated or poorly controlled, AVNRT can lead to several problems:

• Heart failure: Persistent rapid rates can weaken the myocardium over years.
• Syncope or sudden cardiac arrest: Very rare but possible in prolonged or extremely fast episodes.
• Thromboembolic events: Although more common in atrial fibrillation, very rapid rates may promote stasis in the atria.
• Psychological impact: Anxiety, depression, or reduced quality of life due to fear of episodes.
• Medication side effects: Beta‑blockers can cause bradycardia, fatigue, or bronchospasm; calcium‑channel blockers may cause constipation or edema.

When to Seek Emergency Care

References

1. American Heart Association. “Supraventricular Tachycardia (SVT).” 2023. heart.org.
2. Jais P, et al. “Catheter Ablation of AV Nodal Re‑entrant Tachycardia: Long‑Term Outcomes.” *Circulation*. 2022;145(10):842‑850.
3. Mayo Clinic. “AV Nodal Re‑entrant Tachycardia (AVNRT).” Updated 2024. mayoclinic.org.
4. Cleveland Clinic. “Supraventricular Tachycardia (SVT) – Diagnosis & Treatment.” 2023. clevelandclinic.org.
5. National Institutes of Health. “Arrhythmia Statistics.” 2022. nih.gov.

```